In a groundbreaking partnership, the Centre for Medicinal Cannabis (CMC) and the Association for the Cannabinoid Industry (ACI) have teamed up with Chem ID to revolutionize the UK’s legal cannabis industry’s commitment to product authenticity, validation, and quality assurance. CMC and ACI are delighted to announce a strategic partnership with Chem ID, a leading provider …
Category archives: News
CMC publishes new media resource for journalists covering CBD and medical cannabis in the UK
What’s the difference between Medical Cannabis and CBD? The following resource helps media ensure their facts are correct when referring to medicinal cannabis, cannabis oil and over-the-counter CBD products.
Glass Pharms joins the Centre for Medicinal Cannabis
Glass Pharms, awarded the first UK commercial licence to supply high-THC cannabis flower to lawful third parties, has joined the Centre for Medicinal Cannabis. The Home Office granted Glass Pharms with the licence in 2021, following three years of patients and clinicians obtaining imported products, which the company says has resulted in ‘inconsistency of quality …
Continue reading “Glass Pharms joins the Centre for Medicinal Cannabis”
CMC Appoints Professor Trevor Jones as Chief Scientific Advisor
The Center for Medicinal Cannabis today announced the appointment of Professor Trevor Jones CBE to the role of Chief Scientific Advisor (CSA). Professor Jones is well known internationally for his activities in the pharmaceutical industry, biotech industry and academia. His extensive resume includes, Board Director for Research & Development at The Wellcome Foundation Ltd (Wellcome …
Continue reading “CMC Appoints Professor Trevor Jones as Chief Scientific Advisor”
CMC welcomes the recent announcement from the MHRA relating to CBMPs
The Centre for Medicinal Cannabis welcomes the recent announcement from the Medicines and Healthcare products Regulatory Agency (MHRA) regarding the process for approving manufacturing authorisations or API registrations of Cannabis Based Medicinal Products (CBMPs). The piece outlines the MHRA and Home Office licensing requirements for companies and facilities operating within the UK, and provides clarity …
Continue reading “CMC welcomes the recent announcement from the MHRA relating to CBMPs”
CMC co-launches in-depth review of the UK’s cannabinoid industry with 20 key recommendations
CMC co-launches in-depth review of the UK’s cannabinoid industry with 20 key recommendations In February this year following a series of meetings with Ministers, advisers and senior officials in Whitehall the Centre of Medicinal Cannabis and the Association for the Cannabinoid Industry commissioned Oxford University’s Professor Christopher Hodges to oversee a comprehensive review of the …
CMC welcomes Dr Elisabeth Philipps as our new Clinical Advisor
The Centre for Medicinal Cannabis is delighted to announce that Dr Elisabeth Philipps has joined our growing team of esteemed medical experts as our Clinical Advisor. Dr Elisabeth is a clinical neuroscientist and integrative medicine practitioner who founded a consultancy specialising in brain health, the endocannabinoid system and phytocannabinoids including CBD and medicinal cannabis. She …
Continue reading “CMC welcomes Dr Elisabeth Philipps as our new Clinical Advisor”
[Press release] UK Medicinal Cannabis Industry Calls for Bold New Policies to Increase Patient Access and Clinical Understanding of Medicinal Cannabis
UK Medicinal Cannabis Industry Calls for Bold New Policies to Increase Patient Access and Clinical Understanding of Medicinal Cannabis The UK’s industry leadership body, the Centre for Medicinal Cannabis, today launches a report calling on the government to adopt novel, bolder approaches to policy making in relation to medicinal cannabis. Three years after medicinal cannabis was …